Search - tctmd.com

Displaying 841 - 860 of 1117

Sort: Relevancy | Date

News Daily News

Vorapaxar May Protect Against Incident Ischemic Stroke, Stent Thrombosis

Todd Neale

December 04, 2014

News Conference News AHA 2014

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Yael L. Maxwell

November 17, 2014

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Daily News

当将胺碘酮联合华法林使用时，卒中、全身栓塞风险高于阿哌沙班

L.A. McKeown

October 10, 2014

News Daily News

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

L.A. McKeown

October 10, 2014

News Daily News

El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban

L.A. McKeown

October 10, 2014

News Daily News

采用外科手术时的人工瓣膜不匹配率高于TAVR，导致更差结果

October 03, 2014

News Daily News

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

October 03, 2014

News Daily News

La Mayor Discordancia Prótesis-Paciente de la Cirugía frente a la TAVR se asoció a Peores Resultados

October 03, 2014

News Conference News TCT 2014

PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI

September 15, 2014

News Conference News TCT 2014

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2014

Experts Disagree Over Endovascular Therapy for Acute Stroke

September 15, 2014

News Industry News

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

September 13, 2014

News Industry News

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Industry News

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

September 02, 2014

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

Another Strike Against Thrombectomy in 1-Year TASTE Results

Todd Neale

September 02, 2014

Advertisement

Vorapaxar May Protect Against Incident Ischemic Stroke, Stent Thrombosis

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

当将胺碘酮联合华法林使用时，卒中、全身栓塞风险高于阿哌沙班

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban

采用外科手术时的人工瓣膜不匹配率高于TAVR，导致更差结果

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

La Mayor Discordancia Prótesis-Paciente de la Cirugía frente a la TAVR se asoció a Peores Resultados

PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

Keynote Address Focuses on Newer DES, Problematic Subgroups

Experts Disagree Over Endovascular Therapy for Acute Stroke

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

Experts Debate Future of Renal Denervation Therapy

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Another Strike Against Thrombectomy in 1-Year TASTE Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content